Skip to main navigation
Skip to content
Search for:
Contact Us
Search for:
About Us
Locations
Leadership Team
Board of Directors
ABL Bio
Our Expertise
Technology
EpyQ® Production System
Platform Innovation
Gene Therapy Formulation
Scalable Manufacturing
Process Development
Aseptic Fill-Finish
Analytics & GMP QC Testing
Viral Vector Long‑Read NGS
Potency Assay Services
News & Insights
News
Articles
Blogs
Webinar
Events
Resources
Posters
White Papers
Additional Resources
Careers
Contact Us
15 May 2025
Gaining control of rAAV production: real-time monitoring with Raman Spectroscopy
Read More
15 May 2025
High yield & full-empty ratios achieved with a scalable GMP-ready AEX chromatography
Read More
15 May 2025
Extraction-free ddPCR quantification of host-cell derived E1A impurities in rAAV samples
Read More
15 May 2025
ABL’s HIV p24 ELISA Kit: a Solution for Lentivirus Quantification in Industrial Processes
Read More
5 May 2025
Solving the AAV Scalability Challenge
Read More
5 May 2025
Considerations for AAV Analytical Comparability Studies for Products with Low Batch Numbers
Read More
2 May 2025
Gene Therapy Process Development Support to Optimize AAV Yield & Quality from Gene to GMP Production
Read More
2 May 2025
Gene Therapy Formulation
Read More
2 May 2025
Analytics-driven AAV Development & Manufacturing
Read More
2 May 2025
ABL Viral Vector Manufacturing Experts
Read More
2 May 2025
ABL Drug Product Fill/Finish Services
Read More
21 January 2025
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution
Read More
< Back
1
2
3
4
…
6
Next >